Accentia amends Harbinger loan with forebearance agreement

By Elaine Rigoli

Tampa, Fla., July 10 - Accentia BioPharmaceuticals, Inc. has entered into a forebearance agreement for its outstanding $5 million Harbinger Mezzanine Partners loan, paying $2 million of the outstanding balance.

In addition, Harbinger has agreed to forebear in connection with additional payments of remaining principal and interest due until a sale of Accentia assets or closing of an additional financing transaction.

Accentia is a biopharmaceutical company located in Tampa, Fla.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.